The trial, which is called SAP303, was conducted across multiple centers and was open-label. It involved patients who have moderate-to-severe acute pain after the completion of a surgical procedure. Patients involved in the study are 40 years of age or older.
The conference call and webcast were held at 9 a.m. EST with AcelRx sharing the results of the SAP303 trial. The conference call was available to anyone who wished to participate in the United States, Canada and all over the world. It could also be heard online, where a link was also posted to view the webcast. The replay of the webcast is available for 90 days at www.acelrx.com.